Secondary Hyperparathyroidism (SHPT)
Also known as: Secondary hyperparathyroidism (HPT) / Secondary Hyperparathyroidism / Hyperparathyroidism secondary / Secondary hyperparathyroidism (disorder) / Hyperparathyroidism, Secondary
Drug | Drug Name | Drug Description |
---|---|---|
DB01436 | Alfacalcidol | A vitamin D analogue used for the management of hypocalcemia, secondary hyperparathyroidism, and osteodystrophy in patients with chronic renal failure, as well as some types of rickets and osteomalacia. |
DB00146 | Calcifediol | An active metabolite of vitamin D used to treat hyperparathyroidism as well as to combat hypocalcemia in dialysis patients. |
DB00136 | Calcitriol | An active metabolite of vitamin D that is used to treat hyperparathyroidism and is also used in dialysis patients to combat hypocalcemia. |
DB01012 | Cinacalcet | A calcium sensing receptor agonist used to treat secondary hyperparathyroidism in chronic kidney disease and hypercalcemia in parathyroid carcinoma. |
DB06410 | Doxercalciferol | A synthetic vitamin D2 analog used to treat secondary hyperparathyroidism in patients with chronic kidney disease with or without therapy of dialysis. |
DB12865 | Etelcalcetide | A calcium sensing receptor agonist used to treat secondary hyperparathyroidism in patients with chronic kidney disease who require hemodialysis. |
DB00910 | Paricalcitol | A vitamin D analog used to treat hyperparathyroidism associated with stage 3 or greater chronic kidney disease. |